Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Endocrinology|November 15, 2008
Orexin-A hyperphagia: hindbrain participation in consummatory feeding responsesJohn-Paul Baird, Angela Choe, Jasmine L Loveland, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 22, 2002
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patientsM P Glauser, U Brennscheidt, O Cornely, et al.
British Journal of Cancer|March 30, 2006
Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yieldT Seshadri, D Gook, S Lade, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancerP L R Mitchell, R Basser, M Chipman, et al.
Bone Marrow Transplantation|June 20, 2017
An individualised risk-adapted protocol of pre- and post transplant zoledronic acid reduces bone loss after allogeneic stem cell transplantation: results of a phase II prospective trialA Grigg, B Butcher, B Khodr, et al.
Arthritis and Rheumatism|March 20, 1998
Long-term outcome of autoimmune disease following allogeneic bone marrow transplantationJ A Snowden, P Kearney, A Kearney, et al.
Leukemia & Lymphoma|December 29, 1999
Long-term interferon-alpha 2A does not induce sustained hematologic remission in younger patients with essential thrombocythemiaM Bentley, K Taylor, A Grigg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
A phase I dose-escalation study of docetaxel with granulocyte colony-stimulating factor support in patients with solid tumoursP L R Mitchell, R Basser, M Chipman, et al.
Bone Marrow Transplantation|March 7, 2006
Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexateN Murphy, M Diviney, J Szer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2016
Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab)M Rummel, T M Kim, F Aversa, et al.
Pageof 9